Day: June 11, 2021

ST. LOUIS, June 11, 2021 (GLOBE NEWSWIRE) — Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today announced that CFO & COO Tamar Rapaport-Dagim will speak at the 44th Nasdaq Investor Conference on June 15 at 7:00 am ET. The live webcast is available at https://investors.amdocs.com/ and a replay will be available at the same address. Supporting ResourcesLearn more about Amdocs Investor Relations Keep up with Amdocs news by visiting the company’s website Subscribe to Amdocs’ RSS Feed and follow us on Twitter, Facebook, LinkedIn and YouTubeAbout AmdocsAmdocs’ purpose is to enrich lives and progress society, using creativity and technology to build a better connected world. Amdocs and its 27,000 employees partner with the leading players in the communications and media...

Preclinical data demonstrated robust fetal hemoglobin (HbF) induction in erythroid progeny cells with no detection of off-target editing; cells showed reduced sickling and improved rheological behavior RUBY trial of EDIT-301 for sickle cell disease active and recruiting CAMBRIDGE, Mass., June 11, 2021 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced preclinical data supporting the initiation of the EDIT-301 Phase 1/2 RUBY clinical trial to evaluate EDIT-301, a one-time, durable, autologous cell therapy medicine to treat sickle cell disease. EDIT-301 is the first experimental medicine generated using CRISPR/Cas12a gene editing. The Company reported the data in an oral presentation at the 26th Congress of the European Hematology Association (EHA) being held virtually. In these...

ST. JOHN’S, Newfoundland and Labrador, June 11, 2021 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (TSX-V: PNG, OTCQB: KRKNF), Canada’s Ocean Company, is pleased to announce that its wholly owned subsidiary, Kraken Robotic Systems Inc, has signed a Cooperative Research and Development Agreement (CRADA) with Naval Surface Warfare Center, Carderock Division (NSWCCD). Under the CRADA, the Battery Certification and Integration Branch, Code 636 of NSWC Carderock, will test Kraken’s pressure tolerant lithium-ion batteries. The testing is expected to take four months to complete and is expected to start in calendar Q3 of this year. Kraken Comments“We are excited to enter into a CRADA with NSWC Carderock,” said Kraken President & CEO, Karl Kenny. “Since 2018, we have delivered our 6000-meter pressure tolerant batteries to several US and...

HOUSTON, June 11, 2021 (GLOBE NEWSWIRE) — SEACOR Marine Holdings Inc. (NYSE:SMHI) (the “Company” or “SEACOR Marine”), a leading provider of marine and support transportation services to offshore energy facilities worldwide, announced that Falcon Global USA LLC (“FGUSA”), an indirect subsidiary of SEACOR Marine, entered into a second amendment and conditional payoff agreement (the “Conditional Payoff Agreement”) in respect of the credit facility of FGUSA, as borrower, and certain of its subsidiaries, dated as of February 8, 2018 administered by JPMorgan Chase Bank, N.A. (as amended, the “FGUSA Credit Facility”). As of June 10, 2021, there was $117.3 million of principal outstanding under the FGUSA Credit Facility. Under the terms of the Conditional Payoff Agreement, the $117.3 million of principal currently outstanding will be deemed...

                                                          Villers-lès-Nancy, 11 June 2021 – 12:00 p.m. (CET) PRESS RELEASE ORDINARY ANNUAL GENERAL MEETING MEETING NOTICE ON-LINE AVAILABILITY OF MEETING MATERIALS PHARMAGEST INTERACTIVE hereby provides notice to shareholders of the Ordinary Annual General Meeting to be held on Tuesday, 29 June 2021 at 5 p.m., at the Company’s registered office located in VILLERS-LÈS-NANCY (Technopôle de Nancy-Brabois – 5 Allée de Saint Cloud). IMPORTANT NOTICE – COVID-19 Despite the continuing health crisis linked to the COVID-19 epidemic, in light of the number of persons normally present at the Company’s general meetings and the characteristics of the meeting rooms of the Company’s registered office, on the one hand, and the goal of promoting dialogue with shareholders on the other hand, the...

BEIJING, China, June 11, 2021 (GLOBE NEWSWIRE) — UP Fintech Holding Limited (Nasdaq: TIGR) (“UP Fintech” or the “Company”), a leading online brokerage firm focusing on global investors, today announced the closing of its public offering of 6,500,000 American Depositary Shares (“ADSs”), each representing 15 Class A ordinary shares of the Company, at a public offering price of US$24.50 per ADS. The Company granted the underwriters a 30-day option to purchase up to an aggregate of 975,000 additional ADSs from the Company at the public offering price. The underwriters fully exercised their option to purchase these additional ADSs. The Company expects to use the net proceeds from the ADS offering to (i) expand its customer base and drive customer engagement with its services, (ii) invest in expanding its products, services and technologies...

  The order of the Tallinn Circuit Court entered into the force, which annulled the fine of the Financial Supervision Authority against Admiral Markets AS. On February 8, 2021, Finantsinspektsioon (FSA) forwarded a decision to Admiral Markets AS notifying the company about an imposed fine. According to the regulator Admiral Markets AS had not acted entirely in accordance with the Securities Market Act, following the crash of Future crude oil prices in April 2020. Admiral Markets AS did not agree with the decision of the FSA and confirmed that it had always acted in the best interests of its clients. The company was confident that regardless of the opinions in the FSA announcement, it operated in accordance with the regulatory framework even when faced with unusual circumstances. Taken all that into consideration, Admiral Markets AS filed...

Orphazyme A/SCompany announcement        No. 15/2021Company Registration No. 32266355Copenhagen – June 11, 2021 – Orphazyme A/S (ORPHA.CO; ORPH), a late-stage biopharmaceutical company pioneering the heat shock protein response for the treatment of rare diseases, today announced that American Depositary Shares (ADSs) representing its ordinary shares on Nasdaq US have since June 10, 2021 experienced extreme volatility in price and trading volume. The company is not aware of any material change in its clinical development programs, financial condition or results of operations that would explain such price volatility or trading volume that has occurred since June 10, 2021. Investors who purchase the company’s ADS or shares may lose a significant portion of their investments if the price of such securities subsequently declines. Orphazyme’s...

Analysis from Phase 2a HOPE-KIDS 1 Study Featured in Oral Presentation Two Real-world Data Studies Demonstrated Sustained Improvements in Hemoglobin with Oxbryta Consistent with Results from the Phase 3 HOPE Study SOUTH SAN FRANCISCO, Calif., June 11, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced new data from the Phase 2a HOPE-KIDS 1 Study that showed children with sickle cell disease (SCD) ages 4 to 11 years treated with Oxbryta® (voxelotor) tablets experienced significant improvements in hemoglobin levels. These data, along with results from two real-world evidence studies of Oxbryta, will be presented at the European Hematology Association (EHA) 2021 Virtual Congress, taking place online June 9-17, 2021. “The encouraging results seen with Oxbryta treatment in younger patients...